Zhai et al., 2021 - Google Patents
The application value of oXiris-endotoxin adsorption in sepsisZhai et al., 2021
View HTML- Document ID
- 8079303536003399079
- Author
- Zhai Y
- Pan J
- Zhang C
- Publication year
- Publication venue
- American Journal of Translational Research
External Links
Snippet
Objectives: This study explored and analyzed the application value of oXiris-endotoxin adsorption technology in patients with sepsis. Methods: 23 sepsis patients hospitalized from January 2018 to September 2019 in our ICU center and received oxiris-endotoxin …
- 239000002158 endotoxin 0 title abstract description 34
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3659—Cannulae pertaining to extracorporeal circulation
- A61M1/3661—Cannulae pertaining to extracorporeal circulation for haemodialysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. haemofiltration, diafiltration
- A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhai et al. | The application value of oXiris-endotoxin adsorption in sepsis | |
| Morgera et al. | Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status | |
| Shoji | Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin) | |
| Jiang et al. | Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis | |
| Mehta et al. | Experience with hemoadsorption (CytoSorb®) in the management of septic shock patients | |
| Zhang et al. | The absorbing filter Oxiris in severe coronavirus disease 2019 patients: A case series | |
| Wan et al. | Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus‐infected acute‐on‐chronic liver failure treated by entercavir: a prospective study | |
| Zhang et al. | Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis | |
| Honore et al. | An update on membranes and cartridges for extracorporeal blood purification in sepsis and septic shock | |
| Liu et al. | Evaluation of plasma exchange and continuous veno‐venous hemofiltration for the treatment of severe avian influenza a (H7N9): a cohort study | |
| Liu et al. | Effects of different blood purification methods on serum cytokine levels and prognosis in patients with acute severe organophosphorus pesticide poisoning | |
| Chu et al. | Clinical effects of hemoperfusion combined with pulse high-volume hemofiltration on septic shock | |
| Kojika et al. | Endotoxin Adsorption Therapy for Septic Shock Using Polymyxin B‐Immobilized Fibers (PMX): Evaluation by High‐sensitivity Endotoxin Assay and Measurement of the Cytokine Production Capacity | |
| Mu et al. | Continuous renal replacement therapy to reduce inflammation in a piglet hemorrhage–reperfusion extracorporeal membrane oxygenation model | |
| Jarczak et al. | Effect of hemadsorption therapy in critically ill patients with COVID-19 (CYTOCOV-19): A prospective randomized controlled pilot trial | |
| Chen et al. | Cytokine clearances in critically ill patients on continuous renal replacement therapy | |
| Arimura et al. | Clinical study of blood purification therapy in critical care in Japan: results from the survey research of the Japan Society for Blood Purification in Critical Care in 2013 | |
| Li et al. | Hemodiafiltration combined with resin-mediated absorption as a therapy for hyperlipidemic acute pancreatitis | |
| Zhou et al. | Application of oXiris-continuous hemofiltration adsorption in patients with sepsis and septic shock: a single-centre experience in China | |
| Ferrari et al. | Clinical assessment of continuous hemodialysis with the medium cutoff EMiC® 2 membrane in patients with septic shock | |
| Tsuchida et al. | Blood purification for critical illness: cytokines adsorption therapy | |
| Hassan et al. | Coupled Plasma Filtration Adsorption (CPFA) plus Continuous Veno-Venous Haemofiltration (CVVH) versus CVVH alone as an adjunctive therapy in the treatment of sepsis | |
| Zeng et al. | Effects of continuous blood purification without heparin on Strem-1, NSE, and IL-10 levels in patients with sepsis | |
| Yasuda et al. | Removal of 17 cytokines, HMGB1, and albumin by continuous hemofiltration using a cellulose triacetate membrane: an ex vivo study | |
| Nakamura et al. | Adsorption of nafamostat mesilate on AN69ST membranes: a single‐center retrospective and in vitro study |